Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone versus placebo for prevention of preterm birth in twin pregnancies
ISRCTN66445401Phase 3Completed
- Sponsor
- Foundation for Health Education & Research
- Start
- May 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial in preterm birth comparing Progesterone with Placebo (2 arms). Primary endpoint: Incidence of spontaneous delivery before 34 weeks of gestation. Started May 2017; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on ISRCTN66445401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN66445401.